BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™


Company Profiles

Research Store

Research Events
Post an Event
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Patent News (World)
Genticel Granted Five New Patents In The Us And Asia During First Half Of 2014 7/24/2014
Drawbridge Pharmaceuticals Extends Phaxan™ Patent Portfolio With Divisional Patents Granted For Other Neuroactive Steroids 7/22/2014
BMC To Actively Defend Against Curative In Patent Fight 7/18/2014
Prima Biomed (PRR.AX) Receives U.S. Patent Grant For CVac 7/16/2014
C4X Discovery Patent Granted In Japan 7/15/2014
Microbix Biosystems Inc. (MBXBF) Sues Novartis AG (NVS) For Infringement Of Its VIRUSMAX® Patent In Europe 7/10/2014
Pharmalink AB's Core Patents For Nefecon® Treatment For Renal Disease Granted In United States, Europe, China And Hong Kong 7/10/2014
Access Pharmaceuticals (ACCP) Awarded Hong Kong Patent For MuGard 7/8/2014
BioLight Announces Issuance Of U.S. Patent For The Long-Term Controlled-Release Drug-Delivery Insert Platform 7/2/2014
Orexo AB (ORXOF) Commences Patent Infringement Litigation Against Actavis (ACT) 6/27/2014
TWi Biotechnology Receives Notice Of Patent Allowance For Its Lead Drug Candidate AC-201 In United States 6/26/2014
Pluristem Therapeutics (PSTI) Granted Patent In Russia For Treatment Of Inflammatory Bowel Disease Using Placenta-Derived Cells 6/19/2014
Arjuna Natural Extracts Ltd Receives Two Japanese Patents For BCM- 95® 6/18/2014
Teva Pharmaceutical Industries Limited (TEVA) Reaches Settlements In NUVIGIL® Patent Case 6/17/2014
Pluristem Therapeutics (PSTI) Receives Patent In India For Cell Therapy Production Methods And Compositions 6/16/2014
Milan District Court Confirms The Validity Of Alfa Wasserman's Rifaximin-Alpha Patents 6/12/2014
Galmed Pharmaceuticals Announces The Filing Of A Provisional Patent Application For The Use Of Aramchol For The Treatment Of Lipodystrophy 6/9/2014
Scancell: DNA ImmunoBody Patent Granted In United States 6/5/2014
Suven Life Sciences Ltd Secures One Product Patent In U.S.A. 6/4/2014
ERYtech Pharma Strengthens Its Intellectual Property Portfolio 6/2/2014
Actavis (ACT) Confirms Generic Onglyza® Patent Challenge 5/28/2014
Can-Fite BioPharma (CFBI) Receives Patent In European Union For Treatment Of Liver Function Following Surgery 5/8/2014
Alcobra (ADHD) Issued New US Patent Covering Metadoxine Use For Cognitive Disorders 5/1/2014
Actavis (ACT) Announces Celebrex® Patent Challenge Settlement 4/24/2014
TWi Pharmaceuticals, Inc. Announces Settlement Of Lidoderm® Patent Litigation 4/23/2014
Foamix Announces The Issuance Of Five Additional U.S. Patents 4/21/2014
Drawbridge Pharmaceuticals Announces Successful Clinical Trial Results For Phaxan™ And Grant Of U.S. Patent 4/16/2014
Depomed, Inc. (DEPO) Announces Settlements With Two Gralise® ANDA Filers 4/14/2014
Critical Pharmaceuticals Limited Receives Notice Of Allowance From US Patent And Trademark Office For Intranasal Growth Hormone And Parathyroid Hormone Products 4/8/2014
GlaxoSmithKline (GSK)'s ViiV Healthcare Unit Adds New HIV Drug To AIDS Patent Pool 4/2/2014
Enzymotec Provides Update On Patent Litigation With Neptune Technologies & Bioressources Inc. 4/1/2014
Suven Life Sciences Ltd Secures (2) Product Patents For Their NCEs In U.S.A. 3/26/2014
Merck & Co., Inc. (MRK) HIV Drug Strategy Seen Shielding Patent 3/21/2014
Actavis (ACT) Announces Daytrana® Patent Challenge Settlement 3/20/2014
Fibrotech Is Granted U.S. And Canadian Patents For Its Anti-Fibrotic Compounds 3/3/2014
Settlement Between BioPorto And Phadia AB In Patent Case 3/3/2014
Can-Fite BioPharma (CFBI) Granted Patent On The Manufacturing Of CF101 In Japan 2/25/2014
Mallinckrodt Pharmaceuticals (MNK) Receives Patent From U.S. Patent And Trademark Office 2/25/2014
ISA Pharmaceuticals Strengthens Patent Protection For Its Lead Product ISA101 2/24/2014
BioAlliance Pharma: Strengthening And Extension Of The Industrial Protection Of Livatag® Until 2031 2/18/2014
Pluristem Therapeutics (PSTI) Receives Key 3D Cell Expansion Patent In Australia 2/18/2014
Scancell: Publication Of Moditope Patent 2/18/2014
OvaScience (OVAS) Issued Two U.S. Patents Covering AUGMENT? Fertility Treatment 2/12/2014
Actavis (ACT) Confirms Generic Treanda® Patent Challenge 2/4/2014
Enzymotec Announces It Has Been Granted Patents For INFAT®'S Uses In Canada And The US 2/3/2014
Suven Life Sciences Ltd Product Patents For Their NCEs In Canada, China And India 1/31/2014
Microbix Biosystems Inc. (MBXBF) Wins VIRUSMAX® Patent Challenge In Europe 1/23/2014
Anergis Obtains Core Technology Patent In Japan 1/14/2014
BrainStorm Cell Therapeutics Inc. Receives United States Patent Office Notice Of Allowance For Its Stem Cell Technology 1/13/2014
Adocia Strengthens Its Diabetic Foot Ulcer Patent Portfolio 1/13/2014
Suven Life Sciences Ltd Three (3) Product Patents For Their Nces In Australia, Sri Lanka And South Korea 1/9/2014
Veloxis Pharmaceuticals A/S (VELO) Receives Notice Of Allowance From U.S. Patent Office For Diurnal-Independent Administration Of Envarsus® 1/8/2014
BrainStorm Cell Therapeutics Inc. Receives Notice Of Allowance To Grant European Patent Covering Its Stem Cells For The Treatment Of CNS Diseases 1/8/2014
Pluristem Therapeutics (PSTI) Receives Key Placental Cell Therapy Patent in Australia 1/8/2014
Enzymotec Granted Patent For A Lipid Preparation Use Method 1/6/2014
Actavis (ACT) Confirms Generic NuvaRing® Patent Challenge 12/27/2013
Caris Life Sciences Receives Patent For Molecular Profiling Service In The People's Republic Of China 12/17/2013
Scancell's DNA ImmunoBody® Patent Granted In Japan 12/12/2013
MorphoSys AG Strengthens European Patent Position On Anti-CD19 Cancer Program MOR208 12/3/2013
Amarin Corporation PLC (AMRN) Announces Notification Of Patent Allowances For U.S. Applications 13/685,281, And 13/685,291 Related To Triglyceride Lowering With A Mixture Of Omega-3 Free Fatty Acid (Including EPA And/Or DHA) In Both The MARINE And ANCHOR Patient Populations 12/2/2013
TopoTarget A/S Release: Allowance Of Key Belinostat Patent In Europe 11/21/2013
Plasticell Release: Additional Family Of CombiCult® Patents Granted In USA, Europe, Australia And Singapore 11/18/2013
BioAlliance Pharma Strengthens Sitavig Patent Protection With New U.S. And South Korean Issued Patents 11/14/2013
Zysis Receives U.S. Patent for Long Acting Oral Aripiprazole Once Weekly 11/13/2013
Suven Life Sciences Ltd Secures Two (2) Product Patents for Their NCEs in U.S.A. and Japan 11/6/2013
Can-Fite BioPharma (CFBI) Release: U.S. Patent and Trademark Office Grants a Patent for the Reduction of Intraocular Pressure 11/6/2013
Enzymotec Granted Patent for Its Composition of Vayacog® Addressing Memory and Mild Cognitive Impairment 10/30/2013
Drawbridge Pharmaceuticals Granted New Anaesthesia Patents for Phaxan™ 10/28/2013
Immunicum's Patent Application Regarding the Company’s Core-Technology for Therapeutic Cancer Vaccination Using Allogeneic Dendritic Cells is Being Approved in the U.S. 10/25/2013
Merus Granted European Patent on MeMo®, a Transgenic Mouse for Generating the Building Blocks of Therapeutic Human Bispecific Antibodies 10/23/2013
Mystic Pharmaceuticals Receives Notices of Allowance From Japan and China on Drug Delivery Platform Technologies 10/1/2013
Suven Life Sciences Ltd Secures Three (3) Product Patents for Their New Chemical Entities, Inc.'s in New Zealand, Singapore and South Korea 9/25/2013
Mylan Inc. (MYL) Will Not Shy Away From Pursuing "Frivolous" Patents 9/12/2013
Pluristem Therapeutics (PSTI) Granted Key U.S. Patent for the Treatment of Peripheral Artery Disease 9/11/2013
Roche (RHHBY) Gives Up on India Patent for Breast Cancer Drug 8/16/2013
Suven Life Sciences Ltd Secures Two (2) Product Patents for Their New Chemical Entities, Inc.'s in Europe 8/8/2013
Roche (RHHBY) Cancer Drug Suffers Patent Setback in India 8/6/2013
China's SIPO Voids Patent for Gilead Sciences, Inc. (GILD)'s Viread 7/30/2013
Indian Ministry Wants to Cancel Patent on Roche (RHHBY) Cancer Drug 7/26/2013
Riboxx Announces RNA Manufacturing Patent Grant by EPO 7/17/2013
Genetic Technologies Limited (GTG.AX) Announces U.S. Patent Office Allows First Patent for ImmunAid 7/10/2013
Suven Life Sciences Ltd Secures Two Product Patents for Their NCEs in Japan and U.S.A. 6/28/2013
As Field Hots Up, Virttu Biologics Secures U.S. Patent Allowance on Next-Generation Oncolytic Virus Candidates Engineered to Express Antisense Sequences 6/25/2013
Kamada Ltd. (KMDA.TA) Granted Two Key Patents 6/24/2013
Anergis Files Provisional U.S. Patent on AllerDM Dust Mite Allergy Treatment 6/13/2013
QRxPharma Pty Ltd. Granted US Patent on Hybrid Opioids 6/12/2013
Patrys Limited (PAB.AX) Granted Key Patent for Lead Product – PAT-LM1 6/7/2013
Ockham Overturns Vectura Group plc (VEC.L)'s Challenge to Secure European Patent Rights for Inhaled Heparin in the Treatment of COPD 6/3/2013
Verva Pharmaceuticals Announces Grant of United States Patent for Type 2 Diabetes Therapy VVP808 and Results of Annual General Meeting 6/3/2013
New Japanese Protozoal Patent for BioDiem Ltd. (BDM.AX)'s BDM-I 5/22/2013
Amarin Corporation PLC (AMRN) Announces Notification of Patent Allowance for U.S. Application 13/417,899 Related to Combination Product of Vascepa® and Statin Therapy 5/22/2013
European and U.S. Cellulase Patents Granted to DIREVO Industrial Biotechnology GmbH 5/21/2013
Biotage AB (BIOTa.ST) and Peptide Synthesis 5/13/2013
Suven Life Sciences Ltd Secures Three Product Patents for Their NCEs in Canada and Eurasia 5/10/2013
Novartis AG (NVS) Sees Boost From Program Designed to Speed Life-Saving Therapies 5/6/2013
Teva Pharmaceutical Industries Limited (TEVA) Welcomes Landmark "Victory for Patient" in Intellectual Property Case 4/30/2013
Imugene Limited (IMU.AX) Granted Chinese Patent for Novel Drug Delivery Technology 4/30/2013
Medgenics, Inc. Receives Notice of Allowance From the U.S. Patent Office for Claims That Expand IP for Its Platform Technology to Additional Therapeutic Proteins 4/22/2013
Addex Therapeutics (ADXN.SW) Announces Issuance of a Broad European Composition of Matter Patent for Dipraglurant 4/22/2013
ARTES Biotechnology Issued New Patent in Australia for VLP Technology 4/22/2013
GW Pharmaceuticals Announces U.S. Patent Allowance for SATIVEX® Formulation Spray Device 4/22/2013
Celsus Therapeutics Announces Notification of Patents Granted 4/17/2013
Prima Biomed (PRR.AX) Awarded Japanese Patent for CVac™ 4/17/2013
Suven Life Sciences Ltd Secures 4 Product Patents for Their NCEs in China, Mexico and New Zealand 4/17/2013
Starpharma Holdings Ltd Granted New Drug Delivery Patents 4/17/2013
Glenmark Pharmaceuticals to Respond to Patent Row With Merck & Co., Inc. (MRK) Next Month 4/15/2013
AstraZeneca PLC (AZN) Suffers Fresh Drug Patent Setback in U.S. 4/2/2013
Novartis AG (NVS) Loses Cancer Drug Glivec Patent Case 4/1/2013
European Patent Office to Grant Patent for Macrocure's CureXcell® 3/21/2013
Genetic Technologies Limited (GTG.AX) Provides U.S. Patent Re-Examination Update 3/15/2013
Allergy Therapeutics plc Granted U.S. Patent for Sublingual Administration of MPL Adjuvant and Vaccine Antigens 3/11/2013
Alchemia Granted Key U.S. Patent 3/6/2013
India Rejects Bayer AG (BAY.F) Plea Against Cheap Cancer Drug 3/5/2013
Additional Patent Granted in China for BioDiem Ltd. (BDM.AX)'s Antimicrobial 2/21/2013
BioIndustry Association Release: New Patent Court Makes UK Natural European Home for Global Life Science Businesses 2/19/2013
Bristol-Myers Squibb Company (BMY): Patent on $1.4 Billion Hepatitis-B Treatment Invalid; Teva Pharmaceutical Industries Limited (TEVA) to Benefit 2/13/2013
Biotech Support Group Release: Use of Cleanascite™ in "Method and Pharmaceutical Composition for Treatment of Intestinal Disease" 2/12/2013
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Notice of Allowance From Chinese Patent Office for Treatment and Prevention of Heart Disease 2/8/2013
MorphoSys AG Receives First Patent on Novel Antibody Platform Ylanthia in the U.S. 2/8/2013
Mesoblast Limited Release: Key Mesenchymal Precursor Cell Patents Granted in United States and China 2/7/2013
AmpliPhi Biosciences (TGEN) Receives Notice of Allowance on Key Patent for its Bacteriophage Therapy to Treat Drug-Resistant Biofilm-based Infections 2/4/2013
Amarin Corporation PLC (AMRN) Announces Notification of Additional U.S. Patent Allowance for U.S. Application 13/272,520 Based on ANCHOR Clinical Trial Results 2/1/2013
Amarin Corporation PLC (AMRN) Announces Notification of Two Additional Patent Allowances for U.S. Applications (13/458,496 and 13/349,157) Related to Vascepa® and FDA Approved MARINE Indication 1/31/2013
Amarin Corporation PLC (AMRN) Announces First Notification of U.S. Patent Allowance Based on ANCHOR Clinical Trial Results 1/24/2013
Anergis Obtains U.S. Patent for Lead Product AllerT 1/23/2013
Kiadis Pharma Granted U.S. Patent for its Blood Cancer Treatment ATIR™ 1/22/2013
Addex Therapeutics (ADXN.SW) Announces Issuance of a Broad U.S. Composition of Matter Patent for ADX71441 1/22/2013
Biotage AB (BIOTa.ST) Success in Re-Examination Proceedings 1/16/2013
Amarin Corporation PLC (AMRN) Announces Notification of Patent Allowance for U.S. Application 13/610,217 Related to Vascepa® and FDA Approved MARINE Indication 1/11/2013
RedHill Biopharma Ltd. (RDHL) Announces Issuance of New U.S. Patent and Provides Update on RHB-104 for Treatment of Crohn's Disease 1/7/2013
Alkermes plc (ALKS) Announces Notice of Allowance of Key U.S. Patent for Aripiprazole Lauroxil, a New Schizophrenia Drug Candidate 1/3/2013
Suven Life Sciences Ltd Secures 3 Product Patents for Their New Chemical Entities, Inc.'s in Eurasia & Canada 1/2/2013
Amarin Corporation PLC (AMRN) Announces Notification of Patent Allowance for U.S. Application 13/623,450 Related to Vascepa® and FDA Approved MARINE Indication 12/13/2012
Medgenics, Inc. Key Patent Claims Allowed in Japan Protecting Core Technology to be Used in Hepatitis Treatment 12/6/2012
MorphoSys AG Strengthens Patent Position on anti-CD38 Cancer Program MOR202 12/6/2012
Rainbow BioSciences, LLC Target Amarantus BioSciences, Inc. Wins MANF Patent Challenge in Europe 12/5/2012
Takara Bio Grants Patent License to InVivoScribe Technologies, Inc. for FLT3-ITD Testing in Japan 12/5/2012
Axiogenesis Earns U.S. Patent With In Vitro Drug Discovery Assay for Hypertrophic Cardiomyopathy 12/4/2012
Rhenovia Files Two Patent Applications for RHEpatch™, an Electronic Transdermal Patch for Controlled Drug Delivery 11/28/2012
Indian Board Rejects AstraZeneca PLC (AZN)'s Patent Plea on Cancer Drug 11/28/2012
Japanese Patent Office to Grant BioDiem Ltd. (BDM.AX) New Patent for BDM-I Antimicrobial 11/21/2012
Medgenics, Inc. Granted U.S. Patent for Core Technology Used in Sustained Delivery of Erythropoietin, Aimed at Multi-Billion Dollar Anemia Market 11/21/2012
Amarin Corporation PLC (AMRN) Announces Notification of Patent Allowance for U.S. Application 13/608,775 Related to Vascepa® and FDA Approved MARINE Indication 11/19/2012
MediciNova, Inc. Extends MN-166 Patent Position in Europe 11/19/2012
Marinomed Biotechnologie GmbH Granted Chinese Patent for Antiviral Polymer 11/19/2012
New Patent Covering PROLOR Biotech (PBTH)'s Reversible-Pegylation Platform Technology is Allowed by U.S. Patent Office 11/13/2012
India Revokes Roche (RHHBY) Patent in New Blow for Big Pharma 11/5/2012
InDex Pharmaceuticals AB Granted Japanese Patent for Novel Treatment of Steroid-Resistant Inflammation 10/24/2012
Amarin Corporation PLC (AMRN) Announces Issuance of U.S. Patents 8,793,727 and 8,293,728 for Vascepa™ 10/23/2012
Adocia is Extending Its Intellectual Property to New Formulations of Monoclonal Antibodies 10/22/2012
InteRNA Technologies Receives Notice of Allowance for miRNA Sequences of Its Lead Pre-Clinical Product 10/15/2012
Alnylam Pharmaceuticals (ALNY) Announces Tuschl II Key Patent Claims Upheld in Invalidation Trial in Japan 10/9/2012
Laurantis Pharma Oy Issued Patent for Cis-UCA as a Treatment for Bladder Cancer 10/9/2012
Suven Life Sciences Ltd Bags Pharmexcil's "Platinum Patent Award" 10/4/2012
India Revokes Patent for Pfizer Inc. (PFE)'s Sutent 10/4/2012
BioLineRx Ltd. Receives Notice of Allowance From USPTO for New Patent on BL-1020, Extending Patent Protection Until 2031 9/24/2012
Cardiolynx Receives Patent on Improved Angina Pectoris Drug 9/20/2012
Amarin Corporation PLC (AMRN) Announces Notification of Patent Allowance for U.S. Application 13/284,408 Related to Vascepa™ and FDA Approved MARINE Indication 9/6/2012
Amarin Corporation PLC (AMRN) Announces Notification of Patent Allowances for U.S. Applications 12/702,889 and 13/349,153 Related to Vascepa™ and FDA Approved MARINE Indication 9/5/2012
InDex Pharmaceuticals AB Strengthens IP Position for Kappaproct 9/4/2012
Amarin Corporation PLC (AMRN) Announces Notification of Patent Allowance for U.S. Application 13/282,145 Related to Vascepa™ and FDA Approved MARINE Indication 9/4/2012
Public Not to be Hit if Natco Pharma Limited Licence Cancelled: Bayer Corporation (BAY) 9/4/2012
China Botanic Receives New Patent on Its Comprehensive Method to Enhance the Medicinal Value of Schisandra 8/28/2012
U.S. Patent Granted for Verona Pharma's RPL554 8/28/2012
Suven Life Sciences Ltd Secures 4 Product Patents for Their NCEs in Australia, Canada, Korea and New Zealand 8/9/2012
BioDiem Ltd. (BDM.AX) Granted European Patent for BDM-I Antimicrobial 8/7/2012
DiaGenic ASA: Notice of Allowance of Breast Cancer Patent in Japan 8/3/2012
U.S. Patent Office Allows Laurantis Pharma Oy Application for Treatment of Skin Inflammation 8/1/2012
Agennix AG Announces Notice of Allowance for U.S. Patent Application Covering Use of Talactoferrin Alfa to Treat Non-Small Cell Lung Cancer and Renal Cancer in Combination With Other Treatments 7/30/2012
Amarin Corporation PLC (AMRN) Receives Notice of Intention to Grant on European Patent 7/25/2012
BioAlliance Pharma Extends and Strengthens the Protection of AMEP® With the Grant of Two Patents in the US 7/12/2012
BioLineRx Ltd. Receives Notice of Intention to Grant Additional European Patent Covering BL-1020, for the Treatment of Schizophrenia 7/9/2012
Novartis AG (NVS) India Patent Case Postponed to August 22 7/9/2012
Danisco Wins European Patent Office Appeal as Board Revokes Novozymes A/S (NZYMb.CO) Animal Feed Patent 7/6/2012
Amarin Corporation PLC (AMRN) Announces Notice of Allowance for Additional U.S. Patent Covering AMR101 7/2/2012
InnaVirVax Strenghtens Patent Protection of VAC-3S Immunotherapy 6/18/2012
PolyTherics Granted Further Patents for TheraPEG™ and GlycoPol™ 6/18/2012
Bionor Pharma ASA Release: International Patent Application Submitted for the Therapeutic and Potentially Preventive Vaccine Vacc-HIV, Combining Bionor's Vacc-4x and Vacc-C5 6/7/2012
Bionor Pharma ASA Release: International Patent Application Submitted Covering Vaccines for Influenza (Universal Vaccine), Hepatitis C, Cytomegalovirus and Human Papillomavirus 6/7/2012
BioLineRx Ltd. Announces Receipt of Two Notices of Allowance from USPTO for Patents Covering BL-1021, an Orally Available New Chemical Entity for Treatment of Neuropathic Pain 6/5/2012
Rhenovia Files Patents for New Treatment of Huntington's Disease Based on Its Innovative Biosimulation Platform 5/31/2012
Oramed Pharmaceuticals Inc. (ORMP.OB) Granted Core Technology Patent in New Zealand 5/29/2012
Amarin Corporation PLC (AMRN) Announces U.S. Patent Issuance for AMR101 5/29/2012
Patrys Limited (PATZF.PK) Granted Key Patent for Lead Product -- PAT-SM6 5/24/2012
Suven Life Sciences Ltd Secures 4 Product Patents for their NCEs in Japan, Australia, Europe and Eurasia 5/22/2012
Oramed Pharmaceuticals Inc. (ORMP.OB) Granted Israeli Patent for Its Core Technology in Oral Delivery of Proteins 5/16/2012
New US Patent Grant for ValiRx Plc's Cancer Screening Gene Biomarker 5/15/2012
Agenix Limited: New Patent Granted in Japan Enhances Value of Revolutionary New Australian Blood Clot Diagnostic Technology 5/14/2012
Nitto Denko Corporation (XETRA: ND5.DE) Obtains US Patent for Antifibrotic Therapies with Molecular Targeting DDS Technology 5/10/2012
BioDiem Ltd. (BDM.AX) Release: BDM-I Patent Position Strengthened With New US Patent Relating to Malaria and Trichomoniasis 5/3/2012
Quotient Receives Final Patent Approval for Its Enteriontm Technology – the Industry's Leading Clinical Technology for Investigating Drug Absorption 5/1/2012
U.S. Court Invalidates Two Sanofi (France) (SAN.PA) Taxotere Patents 4/11/2012
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Four New Patents and Allowances in Mexico and Israel 4/9/2012
Suven Life Sciences Ltd Secures 4 Product Patents for their NCEs in China and Korea 4/3/2012
Supreme Court Knocks Back Myriad Genetics, Inc. (MYGN) Patents 3/28/2012
Genmab A/S (GEN.CO) Says GlaxoSmithKline (GSK) Settles Patent Case With Genentech (RHHBY) 3/27/2012
Ideal Cures Pvt. Ltd. Receives Key US Patent for Sodium Alginate Based Aqueous Film Coating Technology 3/27/2012
Moraga Biotechnology Corporation Announces Issuance of Adult Stem Cell Patent for Humans 3/20/2012
Silence Therapeutics plc and Other Opponents of Tuschl I Patent Succeed in Limiting Scope and Ambiguity in the Patent 3/9/2012
BioLineRx Ltd. Announces Grant of European Patent Covering BL-1020, an Orally Available Treatment for Schizophrenia 3/7/2012